Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | Key NSCLC updates

Jarushka Naidoo, MBBCh, Beaumont Hospital, Dublin, Ireland, outlines key non-small cell lung cancer (NSCLC) updates from the virtual Gathering Around Cancer 2020 Irish meeting, including novel targeted therapies designed for EGFR, ALK, ROS1, MET and KRAS mutated patients, as well as advances in immunotherapy such as combination ipilimumab and nivolumab which may show benefit in NSCLC patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology)